微小核糖核酸与孤独症谱系障碍的研究进展  被引量:1

Research progress on microRNA and autism spectrum disorders

在线阅读下载全文

作  者:吕伟伟[1] 张光满[1] 许华斌[1] LYU Weiwei;ZHANG Guangman;XU Huabin(Department of Clinical Laboratory,the Second People’s Hospital of Lu’an,Lu’an,Anhui 237008,China)

机构地区:[1]六安市第二人民医院检验科,安徽六安237008

出  处:《安徽医药》2020年第11期2128-2131,共4页Anhui Medical and Pharmaceutical Journal

基  金:安徽省教育厅高校自然科学研究项目(KJ2017A911)。

摘  要:孤独症谱系障碍(ASD)是一种以社会交往障碍、交流障碍、局限刻板的行为为特征的神经发育障碍疾病。虽然ASD病因未明,但是已有研究发现遗传因素在其发病中扮演重要作用,其发病涉及与脑功能和发育相关的多个基因。微小核糖核酸(miRNA)是转录后调控因子,在大脑发育、突触形成和突触可塑性以及记忆形成相关基因的微调中起关键作用。因此,越来越多的研究开始关注miRNA与ASD病理生理学之间的遗传和分子联系,这些发现显示出了miRNA作为ASD的生物标志物和治疗工具的潜力。该文就miRNA与ASD的研究进展作一综述。Autism spectrum disorder(ASD)is a kind of neurodevelopmental disorder,which is characterized by social communication disorder,communication disorder and limited and stereotyped behavior.Although the pathogenesis of ASD is not clear,it has been found that genetic factors play an important role in the pathogenesis of ASD,which involves multiple genes related to brain function and development.MicroRNA(miRNA)is a type of post transcriptional regulatory factor,which plays a key role in the regulation of many genes,including regulation of genes related to brain development,memory formation,synapse formation and plasticity.Therefore,more and more researches begin to pay attention to the relationship between miRNA and the pathophysiology of ASD.These findings show the potential of miRNA as a biomarker and therapeutic tool of ASD.This paper reviews the research progress on miRNA and ASD.

关 键 词:交流障碍 孤独症谱系障碍 微小核糖核酸 生物标志物 突触 综述 

分 类 号:R749.94[医药卫生—神经病学与精神病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象